Researchers established HMGA1 as an epigenetic gatekeeper of Wnt signals and cell state under conditions of Adenomatous polyposis coli inactivation, illuminating HMGA1 as a potential therapeutic target in colon cancer.
[Journal of Clinical Investigation]